渤健Biogen (BIIB) 2016年年度报告「NASDAQ」.pdf

1、 2016 ANNUAL REPORTBIOGEN FORWARDCORPORATE INFORMATIONBoard of DirectorsShareholder InformationCommon Stock PriceStelios Papadopoulos,Ph.D.Chairman,BiogenChairman,Exelixis,Inc.and Regulus Therapeutics,Inc.Michel VounatsosChief Executive Officer,BiogenAlexander J.Denner,Ph.D.Founding Partner,Sarissa

2、CapitalCaroline D.DorsaRetired Executive Vice President and Chief Financial Officer,Public Service Enterprise Group,Incorporated Nancy L.LeamingRetired Chief Executive Officer and President,Tufts Health PlanRichard C.Mulligan,Ph.D.Portfolio Manager,Icahn Capital LP and Mallinckrodt Professor of Gene

3、tics,Emeritus,Harvard Medical School Robert W.PangiaPartner,Ivy Capital Partners,LLCBrian S.PosnerPresident,Point Rider Group LLC and Private InvestorEric K.Rowinsky,M.D.President and Executive Chairman,RGenix,Inc.The Honorable Lynn SchenkAttorney,Former Chief of Staff to the Governor of California

4、and Former U.S.CongresswomanStephen A.Sherwin,M.D.Clinical Professor of Medicine,University of California,San Francisco,and advisor to life sciences companiesCorporate Headquarters Biogen Inc.225 Binney Street Cambridge,MA 02142 Phone:(617)679-2000SEC Form 10-KA copy of Biogens Annual Report on Form

5、 10-K filed with the Securities and Exchange Commission is available at sec.gov and upon request to:Investor Relations Department Biogen Inc.225 Binney StreetCambridge,MA 02142Phone:(781)464-2442Transfer AgentTo keep your contact information current and for shareholder questions regarding lost stock

6、 certificates,address changes and changes of ownership or names in which the shares are held,direct inquiries to:Computershare TrustCompany NA250 Royall StreetCanton,MA 02021Phone:(781)575-2879 Independent Account PricewaterhouseCoopers LLP 101 Seaport Boulevard Boston,MA 02210News ReleasesAs a serv